Live Breaking News & Updates on Her2 Breast Cancer

Stay updated with breaking news from Her2 breast cancer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Screening and Treatment Reduce Breast Cancer Mortality

Simulation models indicate that breast cancer screening and treatment were associated with a 58% reduction in mortality, based on data collected between 1975 and 2019. ....

United States , Surveillance Modeling Network , National Comprehensive Cancer Network Outcomes , Cancer Intervention , Breast Cancer , Alignant Breast Neoplasm , Breast Carcinoma , Breast Cancer Screening , Advanced Breast Cancer , Metastatic Breast Carcinoma , Metastatic Breast Cancer , Dvanced Bc , Etastatic Bc , Etastatic Breast Cancer Mbc , Bc Metastatic Breast Cancer , Alignant Neoplasia , Alignant Neoplasm , Mammary Gland , Her2 Negative Breast Cancer , Her2 Breast Cancer ,

HER2CLIMB-02: Primary Analysis of a Randomized, Double-blind Phase 3 Trial of Tucatinib and Trastuzumab Emtansine for Previously Treated HER2-positive Metastatic Breast Cancer

Sara A. Hurvitz, MD, presents data from the phase 3 HER2CLIMB-02 study investigating tucatinib and trastuzumab emtansine in patients with previously treated HER2+ metastatic breast cancer. ....

San Antonio , United States , Saraa Hurvitz , Trastuzumab Emtansine , Primary Analysis , Double Blind Phase , Previously Treated , Metastatic Breast , Partnership With , Antonio Breast Cancer Symposium , Breast Cancer , Her2 Metastatic Breast Cancer , Her2 Positive Metastatic Breast Cancer , Her2 Breast Cancer , Her2 Positive Breast Cancer , Her2climb 02 , Clinical Implications ,

Study Validates Breast Recurrence Score Across Ethnic Groups

A recent study validated the predictive biomarker's effectiveness in guiding treatment decisions for diverse groups. ....

United States , University Of Illinois , Hsiao Ching Huang , University Of Illinois College Pharmacy , Journal Of The National Comprehensive Cancer Network , Pacific Islander , Hispanic Black , Hispanic White , Illinois College , National Comprehensive Cancer , Breast Cancer , Alignant Breast Neoplasm , Breast Carcinoma , Her2 Negative Breast Cancer , Her2 Breast Cancer , Mammary Gland , Alignant Neoplasia , Alignant Neoplasm , Genomics Genomic Medicine , Etastatic Carcinoma , Metastatic Cancer , Adjuvant Chemotherapy , Iological Marker , Ulti Biomarker Disease Activity ,

Is Axillary Surgery for Abemaciclib Candidacy Overused?

Many women with HR–positive, HER2–negative breast cancer may be exposed to unnecessary axillary surgery, new data show. ....

United States , Fox Chase Cancer Center , Austind Williams , Breast Cancer , Alignant Breast Neoplasm , Breast Carcinoma , Lymph Node Dissection , Lymph Nodes , Her2 Negative Breast Cancer , Her2 Breast Cancer , Genomics Genomic Medicine , Alignant Neoplasia , Alignant Neoplasm , Mammary Gland , Epidermal Growth Factor Receptor , Gfr Epidermal Growth Factor Receptor ,

The Latest Findings on Major Breast Cancer Trials

Here's a roundup of the most recent data from five phase 3 trials presented at SABCS 2023. ....

United States , San Francisco , Jo Chien , Gabriel Hortobagyi , University Of California , Md Anderson Cancer Center , University Of Frankfurt , Antonio Breast Cancer Symposium , Medical News , Cancer Center , Sibylle Loibl , Breast Cancer , Alignant Breast Neoplasm , Breast Carcinoma , Biologic Therapy , Antineoplastic Drug , Nti Cancer Agents , Her2 Positive Breast Cancer , Her2 Breast Cancer , Advanced Breast Cancer , Metastatic Breast Carcinoma , Metastatic Breast Cancer , Dvanced Bc , Etastatic Bc ,